Department of Medicine, Mater Dei Hospital, Malta.
Department of Medical Imaging, Mater Dei Hospital, Malta.
Neuroradiol J. 2022 Apr;35(2):177-182. doi: 10.1177/19714009211034482. Epub 2021 Jul 27.
The aim of this study was to assess the outcomes of endovascular treatment for acute ischaemic stroke in Mater Dei Hospital, Malta and compare them with international data.
A prospective review of all patients who underwent mechanical thrombectomy from 2015 to the end of 2019 was performed. Eligible patients had large vessel occlusion confirmed on computed tomography angiography. Demographical data, the National Institutes of Health stroke scale at presentation, endovascular procedure details and process times were analysed. The thrombolysis in cerebral infarction score was used to assess the degree of reperfusion. A thrombolysis in cerebral infarction score of 2b-3 was considered as successful recanalisation. Functional outcome (modified Rankin scale score) and mortality at 90 days were measured. Functional independence was defined as a modified Rankin scale score of 2 or less.
A total of 132 patients underwent endovascular treatment, one patient was excluded due to incomplete data. The mean age was 71 (range 25-94) years, and the mean National Institutes of Health stroke scale at presentation was 14. Of the 131 patients treated, 69 received intravenous thrombolysis. Successful recanalisation (thrombolysis in cerebral infarction score 2b-3) was achieved in 80% of patients (105/131); 53% of patients (69/131) achieved functional independence at 90 days, with a mortality of 21% at 90 days. Symptomatic intracranial haemorrhage was recorded in 16 patients (12%) There was a statistical difference in the functional independence and mortality rate in favour of the successful recanalisation group.
Our data are consistent with a favourable clinical outcome after successful recanalisation. Service in Malta is achieving favourable outcomes for patients treated with mechanical thrombectomy for acute ischaemic stroke.
本研究旨在评估马耳他圣母医院急性缺血性卒中血管内治疗的结果,并与国际数据进行比较。
对 2015 年底前接受机械取栓治疗的所有患者进行前瞻性回顾。入选患者需经计算机断层血管造影证实为大血管闭塞。分析人口统计学数据、发病时的国立卫生研究院卒中量表评分、血管内手术细节和手术时间。采用血栓溶解评分评估再灌注程度。血栓溶解评分 2b-3 被认为是再通成功。90 天的功能结局(改良 Rankin 量表评分)和死亡率。功能独立定义为改良 Rankin 量表评分为 2 或更低。
共有 132 例患者接受了血管内治疗,1 例因数据不完整而被排除。平均年龄为 71 岁(25-94 岁),发病时平均国立卫生研究院卒中量表评分为 14 分。在 131 例接受治疗的患者中,69 例接受了静脉溶栓治疗。80%的患者(105/131)达到了再通(血栓溶解评分 2b-3);53%的患者(69/131)在 90 天时达到了功能独立,90 天时死亡率为 21%。16 例(12%)出现症状性颅内出血。再通成功组在功能独立和死亡率方面有统计学差异。
我们的数据与成功再通后的良好临床结局一致。马耳他的服务为接受急性缺血性卒中机械取栓治疗的患者取得了良好的效果。